Showing all 2 results
Showing all 2 results
Stiefel, a GSK company is a specialized business unit within GlaxoSmithKline and is focused exclusively on skin health and has local operations in nearly 130 countries. Stiefel is the global leader in the field of dermatology.
Stiefel is renowned for its legacy of innovation in the field of skin health, utilizing a combination of expertise, enthusiasm and imagination to deliver the highest quality, most-effective prescription and over-the-counter skin care products available.
We constantly consult with patients and dermatologists to better understand skin health needs so that we can focus our efforts on products that may make a difference. It’s the patients who need our products and the dermatologists who treat them that fuel Stiefel’s collaborative passion for progress.
Fueled by an insatiable appetite for exploring new ways to advance current thinking, Stiefel brings a wealth of knowledge and real-life experience to every situation. With an unbridled energy level, Stiefel applies resourcefulness and networking qualities toward the relentless pursuit of solution-oriented results.
As a GSK company, we now have access to increased R&D capabilities enabling us to better advance our dermatology pipeline and delivery technologies. GSK screens 65 million molecules per year, which we can now review to find new, innovative dermatology treatment solutions.
Stiefel dermatology: Stiefel has a long history of excellence in dermatology and R&D focused in acne, psoriasis, eczema, atopic dermatitis, and superficial skin infections. Our portfolio ranges from prescription to daily skincare, so that we can offer quality, science-led products that help meet individual treatment needs and improve the overall quality of life for people with skin conditions.
As part of GSK, Stiefel has global reach and capabilities Stiefel benefits from market insights and commercial expertise in both pharmaceutical and consumer healthcare and our products are available in over 130 countries. Through GSK’s emerging markets group, Stiefel is also increasing access to essential skincare products in areas such as central Africa, at sustainable prices.
Stiefel is committed to developing science-led and differentiated products and innovation in areas where it has deep expertise, so that more people discover and enjoy healthy skin.
Our dedicated specialist research team investigates many fundamental aspects of skin science at our Centre for Skin Biology including skin function, disease pathways, protection, repair and regeneration of the skin. We are constantly working to discover more about the disruption of normal, healthy patterns so we can find potential new solutions to both common and rare skin conditions. Stiefel has comprehensive development capabilities in a topical formulation, orals, and injectables for dermatology.
Stiefel also draws upon the extensive R&D capabilities of GSK, collaborating with teams investigating relevant disease pathways in a range of therapy areas, including immuno-inflammation, infectious diseases, oncology, and consumer healthcare.